Regorafenib (monohydrate) (Standard), CAS [[1019206-88-2]]

Produktübersicht

• Artikelname: Regorafenib (monohydrate) (Standard), CAS [[1019206-88-2]]
• Artikelnummer: MCE-HY-10331AR
• Hersteller Artikelnummer: HY-10331AR
• Alternativnummer: MCE-HY-10331AR-100MG,MCE-HY-10331AR-50MG,MCE-HY-10331AR-25MG,MCE-HY-10331AR-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: BAY 73-4506 (monohydrate) (Standard)

Produktbeschreibung

Regorafenib (monohydrate) (Standard) is the analytical standard of Regorafenib (monohydrate). This product is intended for research and analytical applications. Regorafenib (BAY 73-4506) monohydrate is an orally active and potent multi-targeted receptor tyrosine kinase inhibitor, with IC50 values of 13/4.2/46, 22, 7, 1.5 and 2.5 nM for VEGFR1/2/3, PDGFRbeta, Kit, RET and Raf-1, respectively. Regorafenib monohydrate shows very robust antitumor and antiangiogenic activity[1].

Produkteigenschaften

• Molekulargewicht: 500.83
• CAS Nummer: [1019206-88-2]
• Formel: C21H17ClF4N4O4
• Target-Kategorie: Autophagy,c-Kit,FGFR,PDGFR,Raf,Reference Standards,RET,Tie,VEGFR

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference Standards